Compositions and methods for treating proliferative disorders

Details for Australian Patent Application No. 2006301163 (hide)

Owner Universita di Genova Novo Nordisk A/ S Innate Pharma

Inventors Romagne, Francois; Blery, Mathieu; Spee, Petrus Johannes Louis; Moretta, Alessandro; Morch, Ulrik

Agent Davies Collison Cave

Pub. Number AU-B-2006301163

PCT Pub. Number WO2007/042573

Priority 60/726,866 14.10.05 US

Filing date 13 October 2006

Wipo publication date 19 April 2007

Acceptance publication date 23 February 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/042573 Priority application(s): WO2007/042573

23 February 2012 Application Accepted

  Published as AU-B-2006301163

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006301165-Coin dispensing apparatus

2006301162-Chitosan and heparin nanoparticles